基于多组学测量的精神分裂症亚型与免疫失调相关
研究对63例精神分裂症患者和59例健康对照的外周血DNA甲基化谱进行无监督聚类,识别出两个亚型;其中39.7%的患者亚型呈现广泛的甲基化改变、免疫细胞活性相关基因富集及中性粒细胞比例升高,且症状更重、认知更差、白质各向异性降低和灰质增厚。
要点
- 基于外周血DNA甲基化谱可区分精神分裂症的两个生物学亚型。
- 广泛甲基化改变亚型占39.7%,伴免疫相关基因改变和中性粒细胞比例升高。
- 该亚型症状更重、认知更差,且白质各向异性降低和灰质增厚。
核心结论
- 精神分裂症患者中存在一个以广泛DNA甲基化改变、免疫细胞活性相关基因富集及中性粒细胞比例升高为特征的亚型,该亚型症状更重、认知更差且脑结构改变更明显。
研究设计与样本
- 研究纳入63例精神分裂症患者和59例健康对照,采用DNA甲基化芯片进行外周血表观基因组-wide profiling。
- 使用非负矩阵分解(NMF)和k-means聚类识别DNA甲基化相关患者亚型。
- 通过T细胞受体(TCR) repertoire评估分型的有效性,并评估亚型与脑结构和临床测量的关系。
主要发现
- 在患者中识别出两种不同的DNA甲基化谱模式。
- 一个亚型(占患者60.3%)与对照相比甲基化水平和细胞组成变化相对有限。
- 另一个亚型(占患者39.7%)在免疫细胞活性相关基因中呈现广泛的甲基化水平改变,且中性粒细胞比例更高、淋巴细胞比例更低。
- TCR repertoire验证了两个患者亚型的区分,与基于DNA甲基化谱的分型平行。
- 广泛甲基化修饰亚型症状严重度更高、认知测量表现更差,且白质纤维束各向异性降低更明显和灰质增厚证据。
临床怎么用
- 基于外周血DNA甲基化谱和免疫细胞组成的亚型分型可能有助于精神分裂症的个体化治疗开发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epigenetic modifications are plausible molecular sources of phenotypic heterogeneity across schizophrenia patients. The current study investigated biological heterogeneity in schizophrenia using peripheral epigenetic profiles to delineate illness subtypes independent of their phenomenological manifestations. We applied epigenome-wide profiling with a DNA methylation array from blood samples of 63 schizophrenia patients and 59 healthy controls. Non-negative matrix factorization (NMF) and k-means clustering were performed to identify DNA methylation-related patient subtypes. The validity of the partition was tested by assessing the profile of the T cell receptor (TCR) repertoires. The uniqueness of the identified subtypes in relation to brain structural and clinical measures were evaluated. Two distinct patterns of DNA methylation profiles were identified in patients. One subtype (60.3% of patients) showed relatively limited changes in methylation levels and cell composition compared to controls, while a second subtype (39.7% of patients) exhibited widespread methylation level alterations among genes enriched in immune cell activity, as well as a higher proportion of neutrophils and lower proportion of lymphocytes. Differentiation of the two patient subtypes was validated by TCR repertoires, which paralleled the partition based on DNA methylation profiles. The subtype with widespread methylation modifications had higher symptom severity, performed worse on cognitive measures, and displayed greater reductions in fractional anisotropy of white matter tracts and evidence of gray matter thickening compared to the other subtype. Identification of a distinct subtype of schizophrenia with unique molecular, cerebral, and clinical features provide a novel parcellation of the schizophrenia syndrome with potential to guide development of individualized therapeutics.
引用
- Luo C, Pi X, Hu N, et al. Subtypes of schizophrenia identified by multi-omic measures associated with dysregulated immune function. Mol Psychiatry. 2021. PMID: 34588622. doi:10.1038/s41380-021-01308-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。